Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0141 | 0.5 | 0.5 |
Leishmania major | monoglyceride lipase, putative | 0.0141 | 0.5 | 0.5 |
Plasmodium falciparum | esterase, putative | 0.0141 | 0.5 | 0.5 |
Plasmodium vivax | PST-A protein | 0.0141 | 0.5 | 0.5 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.0141 | 0.5 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0141 | 0.5 | 0.5 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0141 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Possible lysophospholipase | 0.0141 | 0.5 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0141 | 0.5 | 0.5 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0141 | 0.5 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0141 | 0.5 | 0.5 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.0141 | 0.5 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0141 | 0.5 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0141 | 0.5 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0141 | 0.5 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0141 | 0.5 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0141 | 0.5 | 0.5 |
Mycobacterium ulcerans | lysophospholipase | 0.0141 | 0.5 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0141 | 0.5 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0141 | 0.5 | 0.5 |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.0141 | 0.5 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0141 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | = -0.02 % | Inhibition of influenza A virus A/PR/8/34(H1N1) neuraminidase assessed as residual activity using MUNANA as substrate after 60 mins by fluorescence analysis | ChEMBL. | 21843936 |
IC50 (binding) | = 4.27 | Inhibition of influenza A virus A/PR/8/34(H1N1) neuraminidase assessed as fluorescent product using MUNANA as substrate after 60 mins by fluorescence analysis | ChEMBL. | 21843936 |
IC50 (binding) | = 53.82 umol/L | Inhibition of influenza A virus A/PR/8/34(H1N1) neuraminidase assessed as fluorescent product using MUNANA as substrate after 60 mins by fluorescence analysis | ChEMBL. | 21843936 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.